NVMDF

Novamind Inc.

Novamind Files Management Information Circular for Special Meeting of Shareholders and Announces Receipt of Interim Court Order for Plan of Arrangement

Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.Shareholders are encouraged to vote their common shares prior to the proxy deadline of June 6, 2022 at 2:00 p.m. ETTORONTO, ON / ACCESSWIRE / May 11, 2022 ... Read More...

Novamind Expands Group Therapy Model

Innovative in-person and virtual group offerings increase access to care and social connectionTORONTO, ON / ACCESSWIRE / March 24, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, announced today that it is launching Groups by Novamind, an expansion of t... Read More...

Novamind Grants Restricted Share Units

Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.TORONTO, ON / ACCESSWIRE / March 11, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psych... Read More...

Novamind Publishes Psychedelic Therapy Patient Case Studies

TORONTO, ON / ACCESSWIRE / February 22, 2022 / Novamind Inc.(CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, today launched Healing Stories, a series of case studies with first-hand accounts of patient experiences with psychedelic-assisted psychotherapy at Novamind clinics (... Read More...

Novamind Appoints Prakash Gowd as Chief Operating Officer

TORONTO, ON / ACCESSWIRE / February 8, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, is pleased to announce that Prakash Gowd has been appointed as the Company's Chief Operating Officer (COO), replacing Pierre Bou-Mansour who is leaving the Company th... Read More...

Novamind Closes Arizona Acquisition

Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.TORONTO, ON / ACCESSWIRE / January 18, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psy... Read More...

Novamind Partners with Uruguay-Based Bienstar Wellness to Develop Latin America’s First Integrative Mental Health Clinic Network

Strategic investment and advisory agreement enables the global expansion of Novamind's psychedelic clinic modelTORONTO, ON / ACCESSWIRE / December 1, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, today announced a strategic investment and advisory agr... Read More...

Novamind Announces Cease Trade Order and Delay in Filing Annual Financial Statements

TORONTO, ON / ACCESSWIRE / November 4, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, today announced that it is the subject of a failure-to-file cease trade order issued by the Ontario Securities Commission on November 3, 2021 as a result of the Compa... Read More...

Novamind Unveils Stealth Mode Investment in Alto Neuroscience

TORONTO, ON / ACCESSWIRE / October 22, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, is pleased to unveil Alto Neuroscience ("Alto"), a clinical-stage biopharmaceutical company, as its previously announced stealth mode investment. In June 2021, Novami... Read More...

Novamind Launches New Psychedelic Palliative Care Program

Specialized program to research and scale access to psychedelic medicine opens new doors for patients with chronic and serious illnessTORONTO, ON / ACCESSWIRE / October 7, 2021 /Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, is pleased to launch Psychedelic P... Read More...

Novamind Opens 5th Clinic Location Specialized in Integrative Psychiatry for Patients with Treatment-Resistant Conditions

Company executes organic growth mandate, on track to open four new clinics by Q3 2021TORONTO, ON / ACCESSWIRE / July 29, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, is pleased to announce that it has completed the construction of a new clinic foc... Read More...